mice require activation of Notch1 for their survival and have accumulated mutations in, or near, the Notch1 PEST domain resulting in increased stability and signaling. In contrast, lymphomas arising in p53 -/-mice show activation of Notch1 but no mutations were identified in ICN. The requirement for Notch1 signaling in E2A -/-lymphomas cannot be overcome by ectopic expression of pTα; however, pTα is required for optimal survival and expansion of these cells. Our findings indicate that activation of Notch1 is an important "second hit" for transformation of E2A -/-T cell lymphomas and that Notch1 promotes survival through both pre-TCR dependent and independent mechanisms.
only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013 . bloodjournal.hematologylibrary.org From Transformation of T lineage cells is a stepwise process that requires deregulated expression or function of multiple oncogenes and tumor suppressors. 1 Aberrant activation of 3 oncogenes, Hox11, Tal-1, and Lyl-1 has been associated with > 50% of T lineage acute lymphoblastic leukemias (T-ALL) in humans. 2 Gene expression analysis has grouped these leukemias into those with a favorable prognosis, associated with Hox11, and those with a poor prognosis, associated with Tal-1 or Lyl-1. Tal-1 and Lyl-1 function as suppressors of E-protein activity and therefore inhibition of E-protein activity is thought to be a frequent feature of T-ALL, particularly T-ALL with a poor prognosis. [3] [4] [5] Consistent with this notion, mice lacking the E-protein transcription factors encoded by the E2A gene succumb to T cell lymphoma with 3-8 months after birth. 6, 7 These lymphomas express CD44, CD25, and varying levels of the co-receptor molecules CD4
and CD8 suggesting an arrest at an early stage of T lymphopoiesis. E2A -/-lymphomas have increased expression of the c-myc oncogene, however, it is not known which oncogenes collaborate with loss of E2A to promote transformation of T lymphocyte progenitors. 6 The E2A gene codes for two basic helix-loop-helix (bHLH) proteins, E12 and E47, through alternative splicing of unique exons encoding the bHLH domain. 8 E2A
proteins are members of the E-protein class of HLH proteins that are widely expressed in mammalian tissues and form homo-or heterodimers with other E-proteins, as well as class II, IV, and V HLH proteins. 9 In T lymphocytes E2A and HEB form heterodimers whereas in B lymphocytes E47 homodimers predominate. 6 ,10 E2A-deficiency leads to an absence of B lymphopoiesis and an incomplete block in early T cell development.
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Despite the reduced number of T lymphocytes in E2A -/-mice, a subset of T cell only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013 . bloodjournal.hematologylibrary.org From progenitors show increased proliferation and rapidly progress to a transformed phenotype. 12 However, the targets of E2A that suppress proliferation or transformation in T lineage cells have not been identified.
The Notch1 protein is a known oncogene that is activated through chromosomal rearrangement in approximately 2% of T-ALL. 13 Recent studies indicate that Notch1 plays a more widespread role in T-ALL than initially predicted since > 50% of T-ALLs 
Materials and Methods

Lymphomas
E2A
-/-lymphomas and the p53 -/-lymphomas 16610D9 and K052FA2C1 were maintained in RPMI (Invitrogen, Carlsbad, CA USA) supplemented with 10% FBS, 5.5 x 10 -5 M 2-mercaptoethanol, 100 u/ml penicillin, 100 μg/ml streptomycin, and 300 μg/ml glutamine and cultured in a humidified incubator with 5% CO 2 . The K052FA2 and K052DA20 lines were maintained in DMEM supplemented with 10% FBS, 5.5 x 10 -5 M 2-mercaptoethanol, 100 u/ml penicillin, 100 μg/ml streptomycin, 300 μg/ml glutamine, 6 mg/ml folic acid, 36 mg/ml asparagine and 116 mg/ml L-arginine HCL and cultured in a humidified incubator with 10% CO 2 . The γ-secretase inhibitors (GSIs) Compound E and DAPT (EMD Biosciences, San Diego, CA USA) were used at a final concentration of 0.5 μM and 10 μM. Primary E2A -/-and p53 -/-lymphomas were derived from animals in The University of Chicago Carlson Barrier Facility.
Flow Cytometry
Cells were analyzed using a FacsCalibur and FlowJo software. 
Northern Blot Analysis
Total RNA was isolated using Trizol Reagent (Invitrogen) and RNA was electrophoresed through a 0.8% formaldehyde/agarose gel and transferred to nylon membrane with 10X SSC as described previously. 24 cDNA probes were made by PCR amplification, cloned into pGEM-T (Promega, Madison, WI USA) and isolated by digestion with NotI and SacII, separated on a 0.8% agarose gel and purified using Qiagen DNA purification kit (Qiagen, Valencia, CA USA). The cDNA was labeled with 32 P using Prime-a-Gene
Labeling System (Promega) and incubated with the membranes in hybridization buffer (50% formamide, 5X SSC, 1% dextran sulphate, 1% Denhardt's, 0.15% SDS, 100 μg/ml sheared and boiled salmon sperm DNA). The membranes were washed 2X at 42 o C in 2X SSC/0.2% SDS followed by 1 wash at 60 o C in 0.2X SSC/0.2% SDS for 30 minutes.
cDNA probes were made from PCR fragments generated using the following primers: only.
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Western Blot Analysis
Whole cell protein extracts were made using previously described methods. 24 The antiNotch1 antibody (V1744) reactive with the cleaved cytoplasmic domain was from Cell
Signaling Technology (Danvers, MA USA) and was used at a dilution of 1:250. The p21 and p27 antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA USA) and were used at a dilution of 1:250.
Retroviral Infection
Retroviral supernatants were made in Phoenix cells and lymphomas were infected by spin-innoculation as described previously. 25 The retroviral constructs MigR1, MigR1-ICN, and MigR1-DNMAML-GFP have been described previously. 17, 18, 26 Construction of the MSCV-pTα retroviral vector (producing hCD25 as a selectable marker) is described in Aifantis et al. 27 The pTα4 siRNA vector was made by PCR amplification of the PTZ plasmid with a U6 sense primer: 5'-GAA GAT CTG GAT CCA AGG TCG GGC AG-3'
and a reverse primer containing the sense-hairpin-antisense sequence: 5'-ccc aag ctt aaa aaa GCT ACA TTG TAC TTA CAT ATA Ggc tac gaa CTA TAT GTA AGT ACA ACG TAG Cgg tgt ttc gtc ctt tcc-3'. The amplified product was digested with BglII and HindIII and ligated into pBanshee. 
Results
Notch1 is activated in E2A
-/-T Cell Lymphomas.
While looking for oncogenes that synergize with loss of E2A to promote transformation of T cell progenitors we discovered that E2A -/-lymphomas express high levels of Notch1 mRNA and activated Notch1 (ICN) protein ( Figure 1A and B).
Moreover, multiple Notch1 target genes including Deltex1, Hes1, Notch3, nRARP, and pTα, are expressed in E2A -/-lymphomas indicating that the Notch1 signaling pathway is functioning in these cells ( Figure 1C ). This was true for all of the available E2A Figure 1A and B) . In contrast to the mutations described by Weng et al. we found no evidence for mutation in the heterodimerization domain of Notch1 suggesting that activation of Notch1 in these cells remains ligand, or at least GS, dependent.
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In contrast to the E2A -/-lymphomas, none of five p53 -/-lymphomas showed evidence of Notch1 mutations within the intracellular domain (Table1). This is a striking difference between E2A -/-and p53 -/-lymphomas and suggests that while Notch1 may be activated in both types of lymphoma the pressure for mutation of Notch1 is different in these two cell types.
For
Activation of Notch1 is Essential for Survival of E2A
-/-Lymphomas.
The absence of mutations in the heterodimerization domain of the Notch1 gene in E2A -/-lymphomas suggests that activation of Notch1 requires GS-dependent processing.
To test the requirement for Notch1 proteolysis in E2A -/-lymphomas we treated lymphoma lines with GS inhibitors (GSI) and measured the effect on cell viability. We found that all of the E2A -/-lymphomas but not the p53 -/-lymphoma 16610D9, which lacks significant Notch1 expression, were dependent on GS activity for their survival For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From MAML showed an increase in reactive oxygen species (ROS), as measured using dihydroethidium (DHE), indicating that DN-MAML is leading to mitochondrial dysfunction and apoptosis in these cells ( Figure 2E ). In contrast, E2A
-/-and p53 -/-lymphomas infected with virus producing GFP only maintained GFP expression for more than 4 days and showed a low level of reactivity with DHE ( Figure 2D and 2E) .
Therefore, GSI and DN-MAML inhibit the survival of E2A -/-lymphomas.
We next examined gene expression in lymphoma lines treated with DMSO, GSI or infected with a DN-MAML producing retrovirus. We found that inhibition of Notch1 signaling with either GSI or DN-MAML antagonized the expression of all of the Notch1 target genes examined ( Figure 3A ). Among the Notch1-dependent genes expressed in E2A -/-lymphomas is pTα, an essential component of the pre-TCR that is required for proliferation, survival and differentiation of T lineage progenitors. 27, 30 Flow cytometric analysis of DMSO and GSI treated cells stained with an anti-TCRβ antibody revealed that inhibition of Notch1 signaling leads to a down-modulation of surface pre-TCR expression ( Figure 3B ). Therefore, inhibition of Notch1 signaling could inhibit proliferation or survival of T cell lymphomas mediated by pre-TCR signaling.
pTα does not rescue GSI induced cell death.
Transformation of E2A -/-lymphocytes can occur in the absence of pre-TCR signaling, however, this does not preclude a role for pre-TCR in E2A -/-lymphomas arising under conditions where the pre-TCR is expressed. 22 Therefore, we examined the role of pTα in Notch1-dependent survival. First we expressed pTα under the control of a retroviral promoter, which is independent of Notch1 signaling, and asked whether pTα only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From could promote survival of E2A -/-lymphomas in the presence of GSI. We found that pTα was not able to promote survival of E2A -/-lymphomas under these conditions even though it was expressed in these cells ( Figure 4A and B) . Therefore, pTα is not sufficient to prevent GSI induced apoptosis.
pTα is required for survival and expansion of E2A -/-lymphomas.
To determine whether pTα is required for survival or expansion of E2A
-/-lymphomas we infected the lymphoma lines with a retrovirus producing siRNA directed against pTα. The percent of cells infected can be measured using GFP, which is expressed from a distinct promoter on the retroviral plasmid. 28 Infection of E2A A previous study demonstrated that pre-TCR signaling promotes survival through regulation of Bcl2A1. 30 However, we found that Bcl2A1 mRNA levels are not altered by Figure 5E ). In contrast, p21 protein levels are not affected by either GSI or pTα siRNA in the 1.F9 lymphoma. The cell cycle inhibitor p27 was not induced by GSI or pTα siRNA in any of the E2A -/-lymphomas whereas a subset of p53 -/-lymphomas showed induction of p27 in response to GSI ( Figure 5E and data not shown).
The observed heterogeneity suggests that there may be multiple targets of pre-TCR only.
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Discussion
We have shown that E2A -/-lymphomas are critically dependent on Notch1 signaling and that Notch1 promotes survival and proliferation of these cells, in part, through induction of pTα. Our data demonstrate that, while suppression of E2A activity may be a consequence of Notch1 signaling, additional Notch1 target genes play a major role in transformation of E2A -/-lymphocytes. While Notch1 is known to regulate expression of at least five genes in T lymphocyte progenitors, none of these genes are likely to promote survival of E2A -/-lymphomas in the absence of Notch1 signaling.
Neither pTα nor Hes1 are sufficient to rescue survival of E2A -/-lymphomas after GSI treatment ( Figure 4 and data not shown). Moreover, nRARP and Deltex1 are inhibitors of Notch1 signaling and are therefore unlikely to overcome the phenotype of loss of Notch1 signaling. 31,32 Therefore, novel targets of Notch1 are likely to be involved in the survival of T cell lymphomas and remain to be identified.
E2A
-/-lymphomas have accumulated mutations in or near the PEST domain, which mediates degradation of the active form of Notch1. Interestingly, p53 -/-lymphomas did not show evidence of mutation in the intracellular domain even though Notch1 is highly expressed and required for the survival of these lymphomas. There appears to be a reciprocal antagonism between Notch1 and p53 that may influence the need for mutation of Notch1 in p53 -/-lymphomas. Notch1 has been shown to inhibit p53 protein expression and this is essential for the ability of Notch1 to promote transformation. 33 However, our only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From data demonstrate that even in the absence of p53 Notch1 signaling is essential for the survival of thymic lymphomas. In addition, p53 inhibits Notch1 transcription and therefore loss of p53 may lead to increased levels of Notch1 and ICN without the need for mutation. 34 The pattern of mutations observed in the lymphomas examined in this study are consistent with a recent study by O'Neil et al 35 in which many p53 -/-lymphomas did not have mutations in the intracellular domain whereas Tal-1 transformed cells
showed mutations in the PEST domain. Taken together, the findings suggests that the first mutation occurring in the stepwise progression to transformation may determine the need for mutation of Notch1 in this process.
Our data suggest a model in which Notch1 promotes transformation through activation of multiple pathways including induction of pre-TCR expression, inhibition of E-protein activity, and at least one additional pathway that remains to be characterized. It remains possible that the additional pathways (or target genes) utilized by Notch1 to promote transformation may vary between independent lymphomas. We have found that
Notch1 influences the expression of a unique set of genes in each of the lymphoma lines that we have examined (data not shown). Similarly, the targets of pre-TCR signaling in each of these lymphoma lines appear to be heterogeneous. We have found evidence for induction of the cell cycle inhibitor p21 in at least one E2A -/-lymphoma after treatment with GSI or pTα siRNA, however, a second lymphoma line failed to induce p21 under similar experimental conditions. Additional experiments will be required to determine whether a few common targets of pre-TCR or Notch1 are essential for lymphoma survival or whether a diverse array of targets function in these cells.
The targets of Notch1 and pre-TCR may be diverse in lymphomas and normal signaling pathways may also be altered as a consequence of transformation. A recent study by Ciofani and Zuniga-Pflucker indicates that Notch1 signaling promotes survival of primary thymocytes through an Akt-dependent metabolic pathway. 36 In contrast, we found that phosphorylation of Akt is not dependent on Notch1 signaling in E2A
-/-lymphomas indicating that Notch1 does not promote survival of lymphomas through regulation of Akt (data not shown). This observation suggests that there is a loss of dependence of Akt phosphorylation on Notch1 during the process of transformation.
Moreover, it suggests that the array of target genes identified for Notch1 in primary cells may differ from those that function in the generation of, or survival of, T cell lymphoma.
Our findings, and recent findings by others, indicate that Notch1 activation is a frequent event in transformation of T cell progenitors in mice. 37 only.
